Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Edwards Lifesciences Corporation

Market Cap 49.68B 42.81B 39.43B 37.02B 69.5B 4,697B 70.23B 466B 181B 2,300B 186B 182B 7,971B P/E Ratio 2026 *
30.8x
P/E Ratio 2027 * 26.4x
Enterprise Value 46.2B 39.81B 36.66B 34.42B 64.63B 4,368B 65.31B 433B 169B 2,139B 173B 170B 7,412B EV / Sales 2026 *
6.85x
EV / Sales 2027 * 6.02x
Free-Float
87.23%
Yield 2026 *
-
Yield 2027 * -
1 day+2.64%
1 week+1.19%
Current month+2.44%
1 month+7.51%
3 months+6.01%
6 months+3.82%
Current year+3.91%
1 week 83.17
Extreme 83.17
89.6
1 month 80.57
Extreme 80.57
89.6
Current year 74.66
Extreme 74.66
89.6
1 year 72.3
Extreme 72.3
89.6
3 years 58.93
Extreme 58.93
96.12
5 years 58.93
Extreme 58.93
131.73
10 years 27.04
Extreme 27.04
131.73
Manager TitleAgeSince
Chief Executive Officer 58 10/05/2023
Director of Finance/CFO 43 28/05/2026
Chief Tech/Sci/R&D Officer 51 31/08/2025
Director TitleAgeSince
Chairman 69 06/05/2024
Director/Board Member 62 09/02/2015
Director/Board Member 58 10/05/2023
Date Insider Type Main position Quantity % Market Cap.
05-28Sell

Controller/Auditor

-568 0.0001%
05-26Sell

Executive/Senior Manager

-23,145 0.0040%
05-21Sell

Executive/Senior Manager

-1,500 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+2.61%+1.19%+18.39%-3.65% 49.68B
-0.25%-4.22%+16.82%-11.93% 176B
+0.28%-2.35%-19.74%+26.48% 148B
+0.43%-3.63%-9.72%-24.91% 128B
+0.46%-4.24%-53.80%-13.69% 69.5B
+0.97%+0.60%-23.33%-33.14% 45.26B
-1.29%-4.91%+8.24%+6.36% 36.88B
+1.57%-2.30%+4.26%+34.71% 35.13B
-2.29%-4.58%-13.55%-19.91% 29.46B
+0.75%-1.48%-22.90%-11.42% 27.84B
Average +0.32%-0.84%-9.53%-5.11% 74.55B
Weighted average by Cap. +0.28%-0.63%-7.59%-4.65%

Financials

2026 *2027 *
Net sales 6.75B 5.81B 5.35B 5.03B 9.44B 638B 9.54B 63.27B 24.65B 312B 25.32B 24.78B 1,083B 7.41B 6.39B 5.88B 5.52B 10.37B 701B 10.47B 69.48B 27.07B 343B 27.81B 27.22B 1,189B
Net income 1.62B 1.4B 1.29B 1.21B 2.27B 154B 2.3B 15.23B 5.93B 75.2B 6.1B 5.97B 261B 1.89B 1.63B 1.5B 1.41B 2.65B 179B 2.67B 17.73B 6.91B 87.56B 7.1B 6.95B 303B
Net Debt -3.48B -3B -2.76B -2.59B -4.87B -329B -4.92B -32.65B -12.72B -161B -13.07B -12.79B -559B -5.07B -4.37B -4.03B -3.78B -7.1B -480B -7.17B -47.57B -18.53B -235B -19.04B -18.63B -814B
Logo Edwards Lifesciences Corporation
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (74%); - hemodynamic monitoring systems (9.1%); - other (16.9%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (25%), Japan (5.8%) and other (10.8%).
Employees
16,000
Date Price Change Volume
16/06/26 88.58 $ +2.67% 5,621,566
15/06/26 86.28 $ +1.37% 2,929,807
12/06/26 85.11 $ -0.76% 4,571,613
11/06/26 85.76 $ -0.26% 5,087,226
10/06/26 85.98 $ -1.78% 4,537,874
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
86.28USD
Average target price
96.92USD
Spread / Average Target
+12.34%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!